Veeva Systems Inc. (NYSE:VEEV) Holdings Boosted by International Assets Investment Management LLC

International Assets Investment Management LLC boosted its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 16,580.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 187,322 shares of the technology company’s stock after purchasing an additional 186,199 shares during the period. International Assets Investment Management LLC owned 0.12% of Veeva Systems worth $36,063,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in VEEV. MetLife Investment Management LLC purchased a new position in Veeva Systems during the 1st quarter worth approximately $1,906,000. Dimensional Fund Advisors LP grew its position in Veeva Systems by 1.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 190,289 shares of the technology company’s stock worth $40,430,000 after purchasing an additional 3,286 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in Veeva Systems by 11.5% during the 1st quarter. Sequoia Financial Advisors LLC now owns 1,018 shares of the technology company’s stock worth $216,000 after purchasing an additional 105 shares in the last quarter. National Pension Service boosted its stake in shares of Veeva Systems by 3.0% during the 1st quarter. National Pension Service now owns 195,170 shares of the technology company’s stock valued at $41,466,000 after buying an additional 5,607 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Veeva Systems by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 12,888,204 shares of the technology company’s stock valued at $2,738,229,000 after buying an additional 132,560 shares during the period. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

VEEV has been the subject of a number of research reports. Oppenheimer reissued an “outperform” rating and set a $225.00 target price on shares of Veeva Systems in a research note on Thursday, February 22nd. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Tuesday, April 2nd. Citigroup lifted their target price on shares of Veeva Systems from $240.00 to $264.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Stifel Nicolaus lifted their target price on shares of Veeva Systems from $205.00 to $250.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Finally, Barclays lifted their price objective on shares of Veeva Systems from $240.00 to $245.00 and gave the company an “overweight” rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $234.90.

Insider Transactions at Veeva Systems

In other news, EVP Alan Mateo sold 910 shares of the business’s stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $204.72, for a total transaction of $186,295.20. Following the transaction, the executive vice president now owns 21,983 shares in the company, valued at approximately $4,500,359.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, EVP Alan Mateo sold 910 shares of the company’s stock in a transaction dated Wednesday, January 17th. The shares were sold at an average price of $204.72, for a total value of $186,295.20. Following the sale, the executive vice president now owns 21,983 shares of the company’s stock, valued at $4,500,359.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CMO Eleni Nitsa Zuppas sold 3,000 shares of the company’s stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $204.75, for a total transaction of $614,250.00. Following the completion of the sale, the chief marketing officer now directly owns 19,057 shares in the company, valued at approximately $3,901,920.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,148 shares of company stock worth $4,451,150. 10.98% of the stock is currently owned by company insiders.

Veeva Systems Price Performance

Shares of VEEV opened at $214.97 on Tuesday. The company has a market capitalization of $34.68 billion, a PE ratio of 66.76, a price-to-earnings-growth ratio of 2.17 and a beta of 0.74. Veeva Systems Inc. has a one year low of $160.21 and a one year high of $236.90. The company’s fifty day moving average price is $222.08 and its 200 day moving average price is $202.64.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Thursday, February 29th. The technology company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.11. Veeva Systems had a net margin of 22.24% and a return on equity of 11.26%. The company had revenue of $630.62 million for the quarter, compared to the consensus estimate of $620.75 million. Analysts anticipate that Veeva Systems Inc. will post 4.11 earnings per share for the current year.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.